azacitidine has been researched along with Pyoderma Gangrenosum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| March López, P; Martí, JM; Nicolás Picó, J; Pardo Pastor, J; Pineda, A; Redondo Capafons, S | 1 |
| Alhusayen, R; Buckstein, R; Prica, A; Sade, S; Tseng, E | 1 |
2 other study(ies) available for azacitidine and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Image Gallery: Pyoderma gangrenosum in a patient with myelodysplastic syndrome treated with azacitidine.
Topics: Aged; Azacitidine; Dermatologic Agents; Humans; Male; Myelodysplastic Syndromes; Pyoderma Gangrenosum; Treatment Outcome | 2017 |
Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Female; Humans; Myelodysplastic Syndromes; Pyoderma Gangrenosum | 2015 |